The Importance of Amino Acid Composition in Natural AMPs: An Evolutional, Structural, and Functional Perspective

Antimicrobial peptides (AMPs) are critical components of natural host defense systems against infectious pathogens (Zasloff, 2002; Boman, 2003; Hancock and Sahl, 2006). They are ubiquitous in nature and have been found in nearly all forms of life, ranging from single-celled bacteria to multicellular organisms such as plants and animals. AMPs are short peptides (5–100 amino acids) with an average net charge of +3 (Wang, 2010). They can display broad or narrow-spectrum antimicrobial activities. The fact that AMPs are effective against multidrug resistance pathogens, including suppression of biofilm formation, deserves our attention (Menousek et al., 2012). In addition to direct bacterial elimination, these peptides have regulatory effects on immune systems. Consequently, AMPs are also referred to as host defense peptides (Hancock and Sahl, 2006). To decode the key elements behind the functional diversity of AMPs, we have been taking time and efforts in constructing a comprehensive database that annotates such information. The first version of the Antimicrobial Peptide Database (APD; http://aps.unmc.edu/AP/main.html) was established in 2003 (Wang and Wang, 2004) and the database has since been further developed (Wang et al., 2009). The APD contained 1973 entries as of May 2012. To facilitate our bioinformatic analysis, we will register a peptide into the APD if it is (1) from natural sources; (2) with minimal inhibitory concentration (MIC) of less than 100 μM or 100 μg/mL; (3) less than 100 amino acid residues; and (4) with a characterized amino acid sequence (Wang, 2010). The APD allows users to extract important parameters (e.g., charge, hydrophobicity, motif, and structure) that determine peptide function. In particular, our database enables the generation of the amino acid composition for a select peptide or a family of AMPs with a common feature. This bioinformatic tool thus uncovers the amino acid use in natural AMPs from different sources, with different functions, or three-dimensional structures. This opinion article highlights the critical roles of the amino acid composition in naturally occurring AMPs in terms of evolutional, structural, and functional significance. Moreover, its application in designing and predicting new AMPs will also be discussed.

[1]  Alessandro Tossi,et al.  Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action , 2011, Cellular and Molecular Life Sciences.

[2]  D. Craik,et al.  Decoding the Membrane Activity of the Cyclotide Kalata B1 , 2011, The Journal of Biological Chemistry.

[3]  Xia Li,et al.  APD2: the updated antimicrobial peptide database and its application in peptide design , 2008, Nucleic Acids Res..

[4]  Guangshun Wang,et al.  Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. , 2012, International journal of antimicrobial agents.

[5]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[6]  Ming-Lang Zhao Lantibiotics as probes for phosphatidylethanolamine , 2011, Amino Acids.

[7]  Guangshun Wang,et al.  Identification of Novel Human Immunodeficiency Virus Type 1-Inhibitory Peptides Based on the Antimicrobial Peptide Database , 2010, Antimicrobial Agents and Chemotherapy.

[8]  Guangshun Wang,et al.  Decoding the Functional Roles of Cationic Side Chains of the Major Antimicrobial Region of Human Cathelicidin LL-37 , 2011, Antimicrobial Agents and Chemotherapy.

[9]  H. G. Boman,et al.  Antibacterial peptides: basic facts and emerging concepts , 2003, Journal of internal medicine.

[10]  Zhe Wang,et al.  APD: the Antimicrobial Peptide Database , 2004, Nucleic Acids Res..

[11]  W. A. van der Donk,et al.  Nine Post-translational Modifications during the Biosynthesis of Cinnamycin , 2011, Journal of the American Chemical Society.

[12]  Marc Torrent,et al.  The generation of antimicrobial peptide activity: a trade-off between charge and aggregation? , 2011, Angewandte Chemie.

[13]  Masa Cemazar,et al.  Cyclotides as a basis for drug design , 2012, Expert opinion on drug discovery.

[14]  Guangshun Wang,et al.  De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures , 2012 .

[15]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[16]  Guangshun Wang,et al.  Antimicrobial peptides: discovery, design and novel therapeutic strategies. , 2010 .